Low-concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen-activated protein kinase pathway activation-Reference-Cited by-同舟云学术

Low-concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen-activated protein kinase pathway activation

Published:2015-06-05 Issue:9 Volume:42 Page:881-888
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Roh Mi Ryung¹²,Kim Jung Min³,Lee Sang Hee¹,Jang Hong Sun¹,Park Kyu Hyun³,Chung Kee Yang¹,Rha Sun Young³⁴⁵

Affiliation:

1. Department of Dermatology; Cutaneous Biology Research Institute; Yonsei University College of Medicine; Seoul Korea

2. Department of Dermatology; Wellman Center for Photomedicine; Massachusetts General Hospital; Harvard Medical School; Boston Massachusetts USA

3. Songdam Institute for Cancer Research; Yonsei University College of Medicine; Seoul Korea

4. Department of International Medicine; Yonsei University College of Medicine; Seoul Korea

5. Division of Medical Oncology; Yonsei University College of Medicine; Seoul Korea

Funder

Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Education, Science, and Technology

the Public Welfare & Safety Research Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science, and Technology

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.12950/fullpdf

Reference35 articles.

1. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia;Yuen;Cancer Res,2002

2. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF;Wan;Cell,2004

3. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

4. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib;Sosman;N Engl J Med,2012

5. Inhibition of mutated, activated BRAF in metastatic melanoma;Flaherty;N Engl J Med,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy;Biology Direct;2024-01-04

2. Adverse Effects of Vemurafenib on Skin Integrity: Hyperkeratosis and Skin Cancer Initiation Due to Altered MEK/ERK-Signaling and MMP Activity;Frontiers in Oncology;2022-01-31

3. A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling;Toxicology and Applied Pharmacology;2021-11

4. Inhibition of 6-formylindolo[3,2-b]carbazole metabolism sensitizes keratinocytes to UVA-induced apoptosis: Implications for vemurafenib-induced phototoxicity;Redox Biology;2021-10

5. Complement factor I upregulates expression of matrix metalloproteinase‐13 and ‐2 and promotes invasion of cutaneous squamous carcinoma cells;Experimental Dermatology;2021-05-04